Normocalcaemic hyperparathyroidism

To date, recommendations for the follow-up and treatment of normocalcaemic, primary hyperparathyroidism (nHPT) have not been established due to the scarcity of data on the prevalence, natural history and outcome of medical or surgical management. Kontogeorgos et al. conducted a cross-sectional, retrospective study at Sahlgrenska University Hospital, Gothenburg, Sweden on a random population of 608 men and women to study the prevalence of nHPT and its relationship to morbidity.

They report that nHPT was common, with a prevalence of 11% at follow-up, and was independently related to obesity and treated hypertension. No increase in fractures or cardiovascular disease in subjects with nHPT was seen over a 17-year period.

Read the full article titled ‘Normocalcaemic,vitamin D sufficient hyperparathyroidism –  high prevalence and low morbidity in the general population: A long-term follow-up study, the WHO MONICA project, Gothenburg, Sweden’ by Kontogeorgos et al. in Clinical Endocrinology, 83 pp 277-284.  

DOI: 10.1111/cen.12819